期刊文献+

铜绿假单胞菌的临床分布及对环丙沙星耐药机制的研究 被引量:8

Clinical distribution and drug resistance mechanisms to ciprofloxacin of 287 strains of pseudomonas aeruginosa
下载PDF
导出
摘要 目的分析医院铜绿假单胞菌(PAE)的临床分布和耐药性,并了解其对环丙沙星的耐药机制。方法我院2011年9月-2013年9月收集的287株铜绿假单胞菌。采用琼脂纸片扩散法(K-B法)进行药敏试验,微量肉汤稀释法测定环丙沙星对PAE的最低抑菌浓度(MIC)。应用PCR方法扩增PAE的gyrA、gyrB、parC及parE基因,并测序来确定基因的突变。结果 287株铜绿假单胞菌以痰液标本中分离最多(76.3%);主要感染分布在重症监护室(29.3%)和呼吸内科(22.6%);且对哌拉西林/他唑巴坦及亚胺培南敏感,敏感率均在70%以上;而对氨苄西林及环丙沙星耐药率高,分别达97.9%和44.9%。在45株(环丙沙星MICs≥32μg/ml)铜绿假单胞菌中,有42株均存在gyrA基因突变,且28株存在着gyrA基因和parC基因双突变。结论铜绿假单胞菌多重耐药现象严重,gyrA基因突变是PAE对环丙沙星耐药的主要机制之一。应加强对铜绿假单胞菌的临床分布及耐药性监测,更好地指导临床合理用药,控制医院感染。 Objective To analyze the clinical distribution and drug resistance of pseudomonas aeruginosa (PAE),and explore the drug resistance mechanisms of ciprofloxacin resistant of PAE.Methods 287 strains of PAE were col lected from the hospital patients from Sep 2012 to Sep 2013.Drug resistance testing were performed by K-B disk diffusion method,and minimal inhibitory concentrations (MICs) of ciprofloxacin to PAE were determined by broth micro-dilution method.Genes gyrA,gyrB,parC and parE of PAE were amplified by PCR,then the PCR products were sequenced to identify the mutations in these genes.Results 76.3% P.aeruginosa were isolated from sputum,PAE infection were mostly occurred in ICU (29.3%) and following by department of respiratory diseases (22.6%) ;PAE had a high susceptibility to piperacillin/tazobactam and imipenem,the sensitive rate were over 70.0%;While PAE had the highest resistant rate to ampicillin (97.9 %),following by ciprofloxacin (44.9 %).Among the 45 PAE isolates (MIC of ciprofloxacin≥32 μg/ml),gyrA gene mutations were found in 42 strains,and double mutations of gyrA and parC genes were found in 28 strains.Conclusion Pseudomonas aeruginosa is multi drug resistance,mutation of gyrA gene is one if the main resistant mechanisms of PAE to ciprofloxacin.It's necessary to reinforce the monitoring on clinical distribution and drug resistance of PAE,to guide the rational clinical drug usage and control the emergence of drug resistant strains.
作者 黄兴富 范华
出处 《中国实验诊断学》 2014年第3期437-440,共4页 Chinese Journal of Laboratory Diagnosis
关键词 铜绿假单胞菌 临床分布 耐药性 环丙沙星 耐药机制 Pseudomonas aeruginosa Clinical distribution Drug resistance Ciprofloxacin Drug resistance mechanism
  • 相关文献

参考文献11

二级参考文献69

共引文献384

同被引文献71

  • 1刘立凡,陈佰义.多粘菌素B与美罗培南联合用药对泛耐药铜绿假单胞菌体外抗菌活性的研究[J].中国生化药物杂志,2014,34(2):39-41. 被引量:11
  • 2潘启超.新抗菌药环丙沙星的特点[J].新医学,1993,24(7):376-377. 被引量:17
  • 3Loots K, Revets H, Goddeeris BM. Attachment of the outer membrane lipoprotein ( OprI ) of Pseudomonas aeruginosa to the mucosal surfaces of the respiratory and digestive tract of chickens [ J ]. Vaccine, 2008, 26 ( 4 ) : 546-551.
  • 4Weimer ET, Ervin SE, Wozniak DJ, et al. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa [ J ] . Vaccine, 2009, 27 ( 48 ) : 6762-6769.
  • 5Rahner R, Eckhardt A, Duchne M, et al. Protection of immunosuppressed mice against infection with pseudomonas aeruginosa by monoclonal antibodies to outer membrane protein Oprl [ J ] . Infection, 1990, 18 ( 4 ) : 242-245.
  • 6Rau H, Revets H, Cornelis P, et al. Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever [ J ] . Vaccine, 2006, 24 ( 22 ) : 4757-4768.
  • 7yon Specht BU, Liicking HC, Blum B, et al. The Pseudomonas aeruginosa outer membrane protein I vaccine : immunogenicity and safe administration in man [ J ] . Behring Inst Mitt, 1997, 98 : 326- 337.
  • 8Westritschnig K, Hochreiter R, Wallner G, et al. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers [ J ] . Human Vaccines & Immunotherapeutics, 2014, 10 ( 1 ) : 170-183.
  • 9Stryjewska A, Kiepura K, Librowski T, et al. Biotechnology and genetic engineering in the new drug development. Part IImonoclonal antibodies, modern vaccines and gene therapy [ J ] . Pharmacological Reports, 2013, 65 ( 5 ) : 1086-1101.
  • 10Zhang L, Cai D, Zhao X, et al. Liposomes containing recombinant gp85 protein vaccine against ALV-J in chickens [ J ] . Vaccine, 2014, 32 ( 21 ) : 2452-2456.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部